Fluoroquinolone resistance contributing mechanisms and genotypes of ciprofloxacin- unsusceptible Pseudomonas aeruginosa strains in Iran: emergence of isolates carrying qnr/aac(6)-Ib genes.
CIP-US
FQ
MLST
Mex
PMQR
Pseudomonas aeruginosa
Journal
International microbiology : the official journal of the Spanish Society for Microbiology
ISSN: 1618-1905
Titre abrégé: Int Microbiol
Pays: Switzerland
ID NLM: 9816585
Informations de publication
Date de publication:
Aug 2022
Aug 2022
Historique:
received:
07
06
2021
accepted:
20
10
2021
revised:
08
10
2021
pubmed:
29
10
2021
medline:
27
7
2022
entrez:
28
10
2021
Statut:
ppublish
Résumé
Fluoroquinolones (FQs) including ciprofloxacin (CIP) are key antibiotics for the treatment of Pseudomonas aeruginosa infections, but resistance to FQs is developing as a result of chromosomal mutations or efflux pump effects. Plasmid-mediated quinolone resistance (PMQR) has been recently reported in the Enterobacteriaceae family. This study aimed to investigate the mechanisms of CIP insusceptibility in P. aeruginosa isolates from ICU patients and to characterize their genotypes. A total of 40 ciprofloxacin unsusceptible (CIP-US) P. aeruginosa isolates from Tehran hospitals were recruited in this study. A broth microdilution assay was performed to find acquired resistance profiles of the isolates. All isolates were screened for target-site mutations (gyrA and parC), PMQR genes, and efflux pumps (mexB, D, Y, and E) expression. Clonality was determined by random amplified polymorphic DNA (RAPD)-PCR, and genotyping was performed on 5 selected isolates by analyzing 7 loci in the existing multilocus sequence typing scheme. Thirty-eight out of 40 CIP-US isolates (95%) were categorized as MDR. Seven (17.5%) had gyrA mutation in codons 83, and no mutation was detected in parC; 77.5% of the isolates were positive for PMQR genes. Among PMQR genes, qnrB (30%), qnrC (35%), and qnrD (30%) predominated, while qnrA, qnrS, and aac(6)-Ib genes were harbored by 20.5%, 12.5%, and 15% of the isolates respectively. Efflux pump protein expression was observed in 35% of the isolates. After RAPD-PCR, 19 different genotypes were yielded, and 5 of them were classified into sequence types (STs): 773, 1160, 2011, 2386, and 359. In this first-time study on P. aeruginosa CIP-US strains from Iranian ICU patients, three main CIP unsusceptibility mechanisms were investigated. A single mutation in one CIP target enzyme could explain high CIP resistance. qnr genes in the isolates can be considered as a CIP-unsusceptibility mechanism among studied isolates. Efflux pumps have more contribution in multidrug resistance than CIP susceptibility. CIP-US isolates of this study have not spread from distinct clonal strains and probably emerged from different sources. STs identified for the first time in this study in Iran should be considered as emerging MDR strains.
Sections du résumé
BACKGROUND
BACKGROUND
Fluoroquinolones (FQs) including ciprofloxacin (CIP) are key antibiotics for the treatment of Pseudomonas aeruginosa infections, but resistance to FQs is developing as a result of chromosomal mutations or efflux pump effects. Plasmid-mediated quinolone resistance (PMQR) has been recently reported in the Enterobacteriaceae family. This study aimed to investigate the mechanisms of CIP insusceptibility in P. aeruginosa isolates from ICU patients and to characterize their genotypes.
METHODS
METHODS
A total of 40 ciprofloxacin unsusceptible (CIP-US) P. aeruginosa isolates from Tehran hospitals were recruited in this study. A broth microdilution assay was performed to find acquired resistance profiles of the isolates. All isolates were screened for target-site mutations (gyrA and parC), PMQR genes, and efflux pumps (mexB, D, Y, and E) expression. Clonality was determined by random amplified polymorphic DNA (RAPD)-PCR, and genotyping was performed on 5 selected isolates by analyzing 7 loci in the existing multilocus sequence typing scheme.
RESULTS
RESULTS
Thirty-eight out of 40 CIP-US isolates (95%) were categorized as MDR. Seven (17.5%) had gyrA mutation in codons 83, and no mutation was detected in parC; 77.5% of the isolates were positive for PMQR genes. Among PMQR genes, qnrB (30%), qnrC (35%), and qnrD (30%) predominated, while qnrA, qnrS, and aac(6)-Ib genes were harbored by 20.5%, 12.5%, and 15% of the isolates respectively. Efflux pump protein expression was observed in 35% of the isolates. After RAPD-PCR, 19 different genotypes were yielded, and 5 of them were classified into sequence types (STs): 773, 1160, 2011, 2386, and 359.
CONCLUSION
CONCLUSIONS
In this first-time study on P. aeruginosa CIP-US strains from Iranian ICU patients, three main CIP unsusceptibility mechanisms were investigated. A single mutation in one CIP target enzyme could explain high CIP resistance. qnr genes in the isolates can be considered as a CIP-unsusceptibility mechanism among studied isolates. Efflux pumps have more contribution in multidrug resistance than CIP susceptibility. CIP-US isolates of this study have not spread from distinct clonal strains and probably emerged from different sources. STs identified for the first time in this study in Iran should be considered as emerging MDR strains.
Identifiants
pubmed: 34709520
doi: 10.1007/s10123-021-00220-x
pii: 10.1007/s10123-021-00220-x
doi:
Substances chimiques
Anti-Bacterial Agents
0
Fluoroquinolones
0
Quinolones
0
Ciprofloxacin
5E8K9I0O4U
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
405-415Commentaires et corrections
Type : ErratumIn
Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Références
Abossedgh, Reza, Maryam Ghane, and Laleh Babaeekhou. 2020. 'High frequency of qnr genes in urinary isolates of extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae in Tehran, Iran', Shiraz E-Medical Journal, 21.
Alni RH, Tavasoli F, Barati A, Badarbani SS, Salimi Z, Babaeekhou L (2020) Synergistic activity of melittin with mupirocin: a study against methicillin-resistant S. Aureus (MRSA) and methicillin-susceptible S. Aureus (MSSA) isolates. Saudi J Biol Sci 27:2580–2585
doi: 10.1016/j.sjbs.2020.05.027
Cayci YT, Coban AY, Gunaydin M (2014) Investigation of plasmid-mediated quinolone resistance in Pseudomonas aeruginosa clinical isolates. Indian J Med Microbiol 32:285–289
doi: 10.4103/0255-0857.136567
Ciesielczuk H, Hornsey M, Choi V, Woodford N, Wareham DW (2013) Development and evaluation of a multiplex PCR for eight plasmid-mediated quinolone-resistance determinants. J Med Microbiol 62:1823–1827
doi: 10.1099/jmm.0.064428-0
Curran B, Jonas D, Grundmann H, Pitt T, Dowson CG (2004) Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa. J Clin Microbiol 42:5644
doi: 10.1128/JCM.42.12.5644-5649.2004
Driscoll JA, Brody SL, Kollef MH (2007) The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections. Drugs 67:351–368
doi: 10.2165/00003495-200767030-00003
Dumas J-L, Van Delden C, Perron K, Köhler T (2006) Analysis of antibiotic resistance gene expression in Pseudomonas aeruginosa by quantitative real-time-PCR. FEMS Microbiol Lett 254:217–225
doi: 10.1111/j.1574-6968.2005.00008.x
Solh El, Ali A, Alhajhusain A (2009) Update on the treatment of Pseudomonas aeruginosa pneumonia. J Antimicrob Chemother 64:229–238
doi: 10.1093/jac/dkp201
Farahi RM, Ali AA, Gharavi S (2018) Characterization of gyrA and parC mutations in ciprofloxacin-resistant Pseudomonas aeruginosa isolates from Tehran hospitals in Iran. Iranian Journal of Microbiology 10:242
pubmed: 30483376
pmcid: 6243147
Fey A, Eichler S, Flavier S, Christen R, Höfle MG, Guzmán CA (2004) Establishment of a real-time PCR-based approach for accurate quantification of bacterial RNA targets in water, using Salmonella as a model organism. Appl Environ Microbiol 70:3618
doi: 10.1128/AEM.70.6.3618-3623.2004
Gorgani N, Ahlbrand S, Patterson A, Pourmand N (2009) Detection of point mutations associated with antibiotic resistance in Pseudomonas aeruginosa. Int J Antimicrob Agents 34:414–418
doi: 10.1016/j.ijantimicag.2009.05.013
Gutiérrez O, Juan C, Cercenado E, Navarro F, Bouza E, Coll P, Pérez JL, Oliver A (2007) Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals. Antimicrob Agents Chemother 51:4329
doi: 10.1128/AAC.00810-07
Hamed SM, Elkhatib WF, El-Mahallawy HA, Helmy MM, Ashour MS, Aboshanab KMA (2018) Multiple mechanisms contributing to ciprofloxacin resistance among Gram negative bacteria causing infections to cancer patients. Sci Rep 8:1–10
Hocquet D, Nordmann P, El Garch F, Cabanne L, Plésiat P (2006) Involvement of the MexXY-OprM efflux system in emergence of cefepime resistance in clinical strains of Pseudomonas aeruginosa. Antimicrob Agents Chemother 50:1347
doi: 10.1128/AAC.50.4.1347-1351.2006
Hopkins Katie L, Davies RH, Threlfall EJ (2005) Mechanisms of quinolone resistance in Escherichia coli and Salmonella: recent developments. Int J Antimicrob Agents 25:358–73
doi: 10.1016/j.ijantimicag.2005.02.006
Hunter PR, Gaston MA (1988) Numerical index of the discriminatory ability of typing systems: an application of Simpson’s index of diversity. J Clin Microbiol 26:2465
doi: 10.1128/jcm.26.11.2465-2466.1988
Jacoby, George A, Jacob Strahilevitz, and David C Hooper. 2015. 'Plasmid‐mediated quinolone resistance', Plasmids: Biology and Impact in Biotechnology and Discovery: 475–503.
Jeong J-Y, Kim ES, Choi S-H, Kwon H-H, Lee S-R, Lee S-O, Kim M-N, Woo JH, Kim YS (2008) Effects of a plasmid-encoded qnrA1 determinant in Escherichia coli strains carrying chromosomal mutations in the acrAB efflux pump genes. Diagn Microbiol Infect Dis 60:105–107
doi: 10.1016/j.diagmicrobio.2007.07.015
Kidd, Timothy J, Stephen R Ritchie, Kay A Ramsay, Keith Grimwood, Scott C Bell, and Paul B Rainey. 2012. 'Pseudomonas aeruginosa exhibits frequent recombination, but only a limited association between genotype and ecological setting', PloS one, 7: e44199.
Kotb DN, Mahdy WK, Mahmoud MS, Khairy RMM (2019) Impact of co-existence of PMQR genes and QRDR mutations on fluoroquinolones resistance in Enterobacteriaceae strains isolated from community and hospital acquired UTIs. BMC Infect Dis 19:1–8
doi: 10.1186/s12879-019-4606-y
Laponogov I, Sohi MK, Veselkov DA, Pan X-S, Sawhney R, Thompson AW, McAuley KE, Mark Fisher L, Sanderson MR (2009) Structural insight into the quinolone–DNA cleavage complex of type IIA topoisomerases. Nat Struct Mol Biol 16:667–669
doi: 10.1038/nsmb.1604
Liu J, Yang L, Chen D, Peters BM, Li L, Li B, Zhenbo Xu, Shirtliff ME (2018) Complete sequence of pBM413, a novel multidrug resistance megaplasmid carrying qnrVC6 and blaIMP-45 from Pseudomonas aeruginosa. Int J Antimicrob Agents 51:145–150
doi: 10.1016/j.ijantimicag.2017.09.008
Lyczak JB, Cannon CL, Pier GB (2000) Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist. Microbes Infect 2:1051–1060
doi: 10.1016/S1286-4579(00)01259-4
Magiorakos A-P, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microb Infect 18:268–81
doi: 10.1111/j.1469-0691.2011.03570.x
Mahenthiralingam E, Campbell ME, Foster J, Lam JS, Speert DP (1996) Random amplified polymorphic DNA typing of Pseudomonas aeruginosa isolates recovered from patients with cystic fibrosis. J Clin Microbiol 34:1129
doi: 10.1128/jcm.34.5.1129-1135.1996
Molapour Azam, Peymani Amir, Saffarain Parvaneh, Habibollah-Pourzereshki Narges, Rashvand Pooya (2020) Plasmid-mediated quinolone resistance in Pseudomonas aeruginosa isolated from burn patients in Tehran, Iran. Infect Disord Drug Targets 20:49–55
doi: 10.2174/1871526519666190206205521
Nanvazadeh F, Khosravi AD, Zolfaghari MR, Parhizgari N (2013) Genotyping of Pseudomonas aeruginosa strains isolated from burn patients by RAPD-PCR. Burns 39:1409–1413
doi: 10.1016/j.burns.2013.03.008
Nie Lu, Lv Y, Yuan M, Xinxin Hu, Nie T, Yang X, Li G, Pang J, Zhang J, Li C (2014) Genetic basis of high level aminoglycoside resistance in Acinetobacter baumannii from Beijing China. Acta Pharmaceutica Sinica B 4:295–300
doi: 10.1016/j.apsb.2014.06.004
Nouri Roghayeh, Rezaee Mohammad Ahangarzadeh, Hasani Alka, Aghazadeh Mohammad, Asgharzadeh Mohammad (2016) The role of gyrA and parC mutations in fluoroquinolones-resistant Pseudomonas aeruginosa isolates from Iran. Braz J Microbiol 47:925–30
doi: 10.1016/j.bjm.2016.07.016
Ogbolu DO, Daini OA, Ogunledun A, Alli AO, Webber MA (2011) High levels of multidrug resistance in clinical isolates of Gram-negative pathogens from Nigeria. Int J Antimicrob Agents 37:62–66
doi: 10.1016/j.ijantimicag.2010.08.019
Pang Z, Raudonis R, Glick BR, Lin T-J, Cheng Z (2019) Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies. Biotechnol Adv 37:177–192
doi: 10.1016/j.biotechadv.2018.11.013
Quale J, Bratu S, Gupta J, Landman D (2006) Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates. Antimicrob Agents Chemother 50:1633
doi: 10.1128/AAC.50.5.1633-1641.2006
Rehman A, Patrick WM, Lamont IL (2019) Mechanisms of ciprofloxacin resistance in Pseudomonas aeruginosa: new approaches to an old problem. J Med Microbiol 68:1–10
doi: 10.1099/jmm.0.000873
Sato T, Yokota S-I, Uchida I, Okubo T, Usui M, Kusumoto M, Akiba M, Fujii N, Tamura Y (2013) Fluoroquinolone resistance mechanisms in an Escherichia coli isolate, HUE1, without quinolone resistance-determining region mutations. Front Microbiol 4:125
pubmed: 23745120
pmcid: 3662882
Strateva T, Yordanov D (2009) Pseudomonas aeruginosa—a phenomenon of bacterial resistance. J Med Microbiol 58:1133–1148
doi: 10.1099/jmm.0.009142-0
Thakur YR, Bajaj BK (2006) Antibiotic resistance and molecular characterization of poultry isolates of Salmonella by RAPD-PCR. World J Microbiol Biotechnol 22:1177–1183
doi: 10.1007/s11274-006-9159-8
Tille, Patricia. 2015. Bailey & Scott's diagnostic microbiology-E-Book (Elsevier Health Sciences).
Nguyen V, Kinh TV, Nguyen HT, Nguyen T, Van Le D (2018) Mutations in the gyrA, parC, and mexR genes provide functional insights into the fluoroquinolone-resistant Pseudomonas aeruginosa isolated in Vietnam. Infection and Drug Resistance 11:275
doi: 10.2147/IDR.S147581
Wang F, Kuihai Wu, Sun J, Wang Q, Chen Q, Shouyi Yu, Rui Y (2012) Novel ISCR1-linked resistance genes found in multidrug-resistant Gram-negative bacteria in southern China. Int J Antimicrob Agents 40:404–408
doi: 10.1016/j.ijantimicag.2012.06.016
Zhao L, Wang S, Li X, He X, Jian L (2020) Development of in vitro resistance to fluoroquinolones in Pseudomonas aeruginosa. Antimicrob Resist Infect Control 9:1–8
doi: 10.1186/s13756-020-00793-8